AU4434389A - Aqueous oral pharmaceutical preparation of diclofenac - Google Patents

Aqueous oral pharmaceutical preparation of diclofenac

Info

Publication number
AU4434389A
AU4434389A AU44343/89A AU4434389A AU4434389A AU 4434389 A AU4434389 A AU 4434389A AU 44343/89 A AU44343/89 A AU 44343/89A AU 4434389 A AU4434389 A AU 4434389A AU 4434389 A AU4434389 A AU 4434389A
Authority
AU
Australia
Prior art keywords
diclofenac
oral pharmaceutical
pharmaceutical preparation
aqueous oral
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44343/89A
Other versions
AU624190B2 (en
Inventor
Heidi Affolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU4434389A publication Critical patent/AU4434389A/en
Application granted granted Critical
Publication of AU624190B2 publication Critical patent/AU624190B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to an aqueous oral pharmaceutical formulation of diclofenac, which can be used for treating pain and inflammatory processes, and also to the preparation of such a formulation.
AU44343/89A 1988-11-10 1989-11-02 Aqueous oral pharmaceutical preparation of diclofenac Expired AU624190B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH416788 1988-11-10
CH4167/88 1988-11-10

Publications (2)

Publication Number Publication Date
AU4434389A true AU4434389A (en) 1990-06-07
AU624190B2 AU624190B2 (en) 1992-06-04

Family

ID=4271057

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44343/89A Expired AU624190B2 (en) 1988-11-10 1989-11-02 Aqueous oral pharmaceutical preparation of diclofenac

Country Status (16)

Country Link
EP (1) EP0373103B1 (en)
JP (1) JP2894744B2 (en)
KR (1) KR0152983B1 (en)
AT (1) ATE87476T1 (en)
AU (1) AU624190B2 (en)
CA (1) CA2002472C (en)
DE (1) DE58903964D1 (en)
DK (1) DK175752B1 (en)
ES (1) ES2054089T3 (en)
GR (1) GR3007995T3 (en)
IE (1) IE63482B1 (en)
IL (1) IL92190A (en)
NZ (1) NZ231320A (en)
PT (1) PT92228B (en)
SA (1) SA90100152B1 (en)
ZA (1) ZA898554B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011688A (en) * 1989-02-02 1991-04-30 Calam Henry D Liquid composition for the relief of premenstrual and menstrual discomforts
IT1256616B (en) * 1992-12-02 1995-12-12 Zambon Spa SYRUP CONTAINING N-ACETYL-CISTEIN
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
BR0113102A (en) 2000-08-07 2003-07-08 Ranbaxy Signature Llc Liquid Formulation of Metformin
ITMI20020986A1 (en) * 2002-05-10 2003-11-10 Acraf COMPOSITION BASED ON DICLOFENAC FOR THE TOPICAL TREATMENT OF AFFECTIONS OF THE OROPHARINGOUS CABLE
JP2004059488A (en) * 2002-07-29 2004-02-26 Asahi Food & Healthcare Ltd Lactobacillus intestinal disorder controlling composition and food
JP2006315966A (en) * 2005-04-11 2006-11-24 Sanei Gen Ffi Inc Liquid composition for pharyngolarynx containing black soybean extract
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
CA2852912A1 (en) 2011-10-31 2013-05-10 Glaxosmithkline Intellectual Property Limited Pazopanib formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
DE2629884A1 (en) * 1975-07-04 1977-01-20 Gaba Ag ORAL AND DENTAL CARE PRODUCTS
CH655507B (en) * 1983-01-12 1986-04-30

Also Published As

Publication number Publication date
IE893611L (en) 1990-05-10
AU624190B2 (en) 1992-06-04
KR910009253A (en) 1991-06-28
DK561589D0 (en) 1989-11-09
CA2002472C (en) 2000-05-30
ES2054089T3 (en) 1994-08-01
KR0152983B1 (en) 1998-11-16
IE63482B1 (en) 1995-05-03
DE58903964D1 (en) 1993-05-06
DK175752B1 (en) 2005-02-07
EP0373103A1 (en) 1990-06-13
EP0373103B1 (en) 1993-03-31
PT92228B (en) 1995-07-06
CA2002472A1 (en) 1990-05-10
SA90100152B1 (en) 2001-04-14
NZ231320A (en) 1992-11-25
JPH02178224A (en) 1990-07-11
IL92190A0 (en) 1990-07-26
IL92190A (en) 1996-07-23
ZA898554B (en) 1990-08-29
PT92228A (en) 1990-05-31
ATE87476T1 (en) 1993-04-15
DK561589A (en) 1990-05-11
GR3007995T3 (en) 1993-08-31
JP2894744B2 (en) 1999-05-24

Similar Documents

Publication Publication Date Title
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
AU4524889A (en) Method for the treatment of periodontal disease
GR3019050T3 (en) Dental adhesive
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
GR3006815T3 (en)
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
NO165071C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7- (3-AMINO-1-PYRROLIDINYL) -8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4, -DIHYDRO-4-OXO-3-CHINOLINE-CARBOXYL.
AU4517893A (en) An oral formulation for gastric antibacterial treatment as well as a process thereof and the use
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
AU1971988A (en) Pharmaceutical compositions for the treatment of uraemia
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
AU3709289A (en) Strontium salt
AU6724581A (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
IE870577L (en) Topical amide preparation
AU7071487A (en) Chlorpheniramine therapy
NO165542C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER.
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NO164100C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-CHLORO-S-TRIAZOLO- (4,3-A) -PYRIDINE-7-CARBOXYL ACIDS.
AU7907987A (en) Pharmaceutical composition for the treatment of high blood pressure
AU6975891A (en) Pharmaceutical compositions for the treatment of drug dependence